Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.32 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.32 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.32 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | BCHE | P06276 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | PDE9A | O76083 | 1/20 | 0.31 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.31 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23306885 | 0.92 | KDM4E (0.36) | KDM4EATML3MBTL1MAPTLMNA | |
| SCHEMBL2620742 | 0.92 | KDM4E (0.47) | KDM4EATML3MBTL1ALDH1A1PTPN1 | |
| SCHEMBL2620744 | 0.84 | KDM4E (0.43) | KDM4EATML3MBTL1ALDH1A1PTPN1 | |
| SCHEMBL19938794 | 0.83 | KDM4E (0.40) | KDM4EATML3MBTL1MAPTLMNA | |
| SCHEMBL18411836 | 0.83 | KDM4E (0.36) | KDM4EATML3MBTL1HDAC4 | |
| SCHEMBL16017469 | 0.81 | L3MBTL1 (0.50) | KDM4EATML3MBTL1MAPTHTT | |
| SCHEMBL24715074 | 0.80 | — | — | |
| SCHEMBL19764681 | 0.79 | KDM4E (0.45) | KDM4EATML3MBTL1ALDH1A1CYP19A1 | |
| SCHEMBL16865096 | 0.79 | KDM4E (0.34) | KDM4EATML3MBTL1 | |
| SCHEMBL24161903 | 0.78 | KDM4E (0.33) | KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11839140-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | UDC IRELAND LIMITED (IE) | 2023-12-05 | — | — | US | disclosed |
| US-11839140-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | UDC IRELAND LIMITED (IE) | 2023-12-05 | — | — | US | disclosed |
| US-11765967-B2 | Highly efficient OLED devices with very short decay times | UDC IRELAND LIMITED (IE) | 2023-09-19 | — | — | US | disclosed |
| US-11765967-B2 | Highly efficient OLED devices with very short decay times | UDC IRELAND LIMITED (IE) | 2023-09-19 | — | — | US | disclosed |
| US-20230026258-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | UDC IRELAND LTD (IE) | 2023-01-26 | — | — | US | disclosed |
| EP-4060757-A1 | HIGHLY EFFICIENT OLED DEVICES WITH VERY SHORT DECAY TIMES | UDC Ireland Limited (IE) | 2022-09-21 | — | — | EP | disclosed |
| US-20220149300-A1 | HIGHLY EFFICIENT OLED DEVICES WITH VERY SHORT DECAY TIMES | UDC IRELAND LTD (IE) | 2022-05-12 | — | — | US | disclosed |
| US-20220144869-A1 | HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS | UDC IRELAND LIMITED (IE) | 2022-05-12 | — | — | US | disclosed |
| EP-3304612-B1 | HIGHLY EFFICIENT OLED DEVICES WITH VERY SHORT DECAY TIMES | UDC IRELAND LTD (IE) | 2022-05-04 | — | — | EP | disclosed |
| EP-3916822-A1 | HIGHLY EFFICIENT OLED DEVICES WITH VERY SHORT DECAY TIMES | UDC Ireland Limited (IE) | 2021-12-01 | — | — | EP | disclosed |
| US-8691401-B2 | Bridged benzimidazole-carbene complexes and use thereof in OLEDS | BASF SE (DE) | 2014-04-08 | — | — | US | disclosed |
| WO-2013068376-A1 | 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2013-05-16 | — | — | WO | disclosed |
| US-20130032766-A1 | METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOLOCARBENE LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2013-02-07 | — | — | US | disclosed |
| US-8362246-B2 | Bispyrimidines for electronic applications | BASF SE (DE) | 2013-01-29 | — | — | US | disclosed |
| US-20120319050-A1 | METAL COMPLEXES COMPRISING AZABENZIMIDAZOLE CARBENE LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2012-12-20 | — | — | US | disclosed |
| US-20120205645-A1 | HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2012-08-16 | — | — | US | disclosed |
| US-20120149904-A1 | BISPYRIMIDINES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2012-06-14 | — | — | US | disclosed |
| US-20120095222-A1 | PHENANTHRO[9, 10-B]FURANS FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2012-04-19 | — | — | US | disclosed |
| US-20110309346-A1 | ORGANIC ELECTRONIC DEVICES COMPRISING A LAYER COMPRISING AT LEAST ONE METAL ORGANIC COMPOUND AND AT LEAST ONE METAL OXIDE | BASF SE (DE) | 2011-12-22 | — | — | US | disclosed |
| US-20110253988-A1 | BRIDGED BENZIMIDAZOLE-CARBENE COMPLEXES AND USE THEREOF IN OLEDS | BASF SE (DE) | 2011-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120319050-A1 | METAL COMPLEXES COMPRISING AZABENZIMIDAZOLE CARBENE LIGANDS AND THE USE THEREOF IN OLEDS | OCIAD1, OCIAD2, OXA1L | KDM4E 4412/4885ATM 3454/4885L3MBTL1 3381/4885 |
| US-20120205645-A1 | HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS | OCIAD2, OCIAD1, CLTB | KDM4E 3813/4885ATM 4500/4885L3MBTL1 1656/4885 |
| US-20120149904-A1 | BISPYRIMIDINES FOR ELECTRONIC APPLICATIONS | DPYD, TYMP, TYMS | KDM4E 1622/4885ATM 2950/4885L3MBTL1 3766/4885 |
| US-20220144869-A1 | HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS | OCIAD2, OCIAD1, CLTB | KDM4E 4143/4885ATM 4604/4885L3MBTL1 1926/4885 |
| US-20120095222-A1 | PHENANTHRO[9, 10-B]FURANS FOR ELECTRONIC APPLICATIONS | P2RY10, P2RY11, P2RY12 | KDM4E 1775/4885ATM 4742/4885L3MBTL1 4549/4885 |
| US-20130032766-A1 | METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOLOCARBENE LIGANDS AND THE USE THEREOF IN OLEDS | OCIAD1, OCIAD2, DRD2 | KDM4E 4587/4885ATM 3382/4885L3MBTL1 2826/4885 |
| US-20110253988-A1 | BRIDGED BENZIMIDAZOLE-CARBENE COMPLEXES AND USE THEREOF IN OLEDS | CCND1, DRD2, CCND2 | KDM4E 3589/4885ATM 3853/4885L3MBTL1 1507/4885 |
| US-20230026258-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | OCIAD1, OCIAD2, DRD2 | KDM4E 4573/4885ATM 3351/4885L3MBTL1 2835/4885 |
| US-11839140-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | OCIAD1, OCIAD2, DRD2 | KDM4E 4573/4885ATM 3351/4885L3MBTL1 2835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.